Clinical end point acceptance limit [Study As­sess­ment]

posted by ElMaestro  – Denmark, 2019-04-05 10:51 (2233 d 11:55 ago) – Posting: # 20126
Views: 4,300

Hello to you too, PKS,

❝ Should I conclude bio-equivalence with the values of [-0.2025, 0.076] in clinical end point study. Can I assume it as within the interval of (-0.20, 0.20)


What does your protocol say on exactly that matter?

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,671 registered users;
149 visitors (0 registered, 149 guests [including 25 identified bots]).
Forum time: 22:47 CEST (Europe/Vienna)

A statistical analysis, properly conducted, is a delicate dissection of
uncertainties, a surgery of suppositions.    Micheal J. Moroney

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5